Kinetic study of Apo B100 containing lipoprotein metabolism using amino acids labeled with stable isotopes: Methodological aspects

Clinical Chemistry and Laboratory Medicine

Volumn 36, Issue 10, 1998, Pages 739-745

  Maugeais, Cyrille ^a   Ouguerram, Khadija ^a   Krempf, Michel ^a,b   Magot, Thierry ^a  

^a HÔTEL DIEU   (France)

^b Clinique d'Endocrinologie Hotel Dieu CHU de Nantes   (France)

Author keywords

Apolipoprotein B; Kinetics; Lipoprotein; Modeling; Stable isotopes

Indexed keywords

AMINO ACID; APOLIPOPROTEIN B100;

BLOOD SAMPLING; CATABOLISM; COMPARTMENT MODEL; GAS CHROMATOGRAPHY; HUMAN; ISOTOPE LABELING; KINETICS; LIPOPROTEIN METABOLISM; MASS SPECTROMETRY; PRIORITY JOURNAL; REVIEW;

EID: 0031775240     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1998.131     Document Type: Review

References (51)

1. Phair RD, Hammond MG, Bowden JA, Fried M, Fisher WR, Berman M. A preliminary model for human lipoprotein metabolism in hyperlipoproteinemia. Federation Proc 1975; 34:2263-70.
2. Fisher WR, Zech LA, Kilgore LL, Stacpoole PW. Metabolic pathways of apolipoprotein B in heterozygous familial hypercholesterolemia: studies with a 3H-leucine tracer. J Lipid Res 1991; 32:1823-36.
3. 75Se-amino acid incorporation into apoprotein. In: Lipoprotein kinetics and modeling. New York: Academic Press, 1982:77-97.
4. Parhofer KG, Barrett PHR, Bier DM, Schonfeld G. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes. J Lipid Res 1991; 32:1311-23.
5. Barrett PHR, Foster DM. Design and analysis of lipid kinetic studies. Curr Opin Lipidol 1996; 7:143-8.
6. Eaton RP, Allen RC, Schade DS. Overproduction of a kinetic subclass of VLDL-apoB, and direct catabolism of VLDL-apoB in human endogenous hypertriglyceridemia: an analytical model solution of tracer data. J Lipid Res 1983; 24:1291-303.
7. Lichtenstein AH, Cohn JS, Hachey DL, Millar JS, Ordovas JM, Schaefer EJ. Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein A-1 and B-100 kinetics. J Lipid Res 1990; 31:1693-701.
8. Patterson BW, Hachey DL, Cook GL, Amann JM, Klein PD. Incorporation of a stable isotopically labeled amino acid into multiple human apolipoproteins. J Lipid Res 1991; 32:1063-72.
9. Yao Z, McLeod R. Synthesis and secretion of hepatic apolipoprotein B-containing lipoproteins. Biochim Biophys Acta 1994; 1212:152-66.
10. Hardman DA, Kane JP. Isolation and characterisation of apolipoprotein B-48. In: Segrest JP, Albers JJ, editors. Methods in enzymology. vol. 128: Plasma lipoproteins. Orlando: Academic Press, 1986:262-72.
11. Wolfe RR. Radioactive and stable isotope tracers in biomedicine. Principles and practice of kinetic analysis. New York: John Wiley, 1992:49-85.
12. Cryer DR, Matsushima T, Marsh JB, Yudkoff M, Coates PM, Cortner JA. Direct measurement of apolipoprotein B synthesis in human VLDL using stable isotopes and mass specrometry. J Lipid Res 1986; 27:508-16.
13. Cohn JS, Wagner DA, Cohn SD, Millar JS, Schaefer EJ. Measurement of VLDL and LDL apolipoprotein (Apo) B100 and HDL Apo A1 production in human subjects using deuterated leucine. J Clin Invest 1990; 85:804-11.
14. Halliday D, Venkatesan S, Pacy PJ. Apolipoprotein metabolism: a stable isotope approach. Am J Clin Nutr 1993; 57:726-315.
15. Maugeais C, Ouguerram K, Krempf M, Maugeais P, Gardette J, Bigot E, et al. A minimal model using stable isotopes to study the metabolism of apolipoprotein B-containing lipoprotein in humans. Diabete Metabolisme 1996; 22:1-7.
16. Reeds PJ, Hachey DL, Patterson BW, Motil KJ, Klein PD. VLDL apolipoprotein B-100, a potential indicator of the isotopic labeling of the hepatic protein synthetic precursor pool in humans: studies with multiple stable isotopically labeled amino acids. J Nutr 1992; 122:457-66.
17. 5] phenylalanine tracers for the measurement of human apolipoprotein B100 Kinetics. J Mass Spectrom 1995; 30:478-84.
18. Egusa G, Brady DW, Grundy SM, Howard BV. Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentration during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B. J Lipid Res 1983; 24:1261-7.
19. Malmström R, Packard CJ, Caslake M, Bedford D, Stewart P, Iki-Järvinen H, et al. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 1997; 40:454-62.
20. Demant T, Packard CJ, Demmalmair H, Stewart P, Bedynek A, Bedford D, et al. Sensitive method to study human apolipoprotein B metabolism using stable isotope-labeled amino acids. Am J Physiol 1996; 270:E1022-E36.
21. Pietzsch J, Wiedemann B, Julius U, Nitzsche S, Gehrisch S, Bergmann S, et al. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach. J Lipid Res 1996; 37:2074-87.
22. Cummings MH, Watts GF, Umpleby M, Hennessy TR, Kelly JM, Jackson C, et al. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetes 1995; 44:1059-65.
23. Knapp DR. Handbook of analytical derivatization reactions. New York: John Wiley, 1979:249-58.
24. Cobelli C, Toffolo G, Foster DM. Tracer-to-tracee ratio for analysis of stable isotope tracer data: link with radioactive kinetic formalism. Am J Physiol 1992; 262:E968-E75.
25. Foster DM, Barrett PHR, Toffolo G, Beltz WF, Cobelli C. Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data. J Lipid Res 1993; 34:2193-205.
26. Thompson GN, Pacy PJ, Ford GC, Halliday D. Practical considerations in the use of stable isotope labelled compounds as tracers in clinical studies. Biomed Environ Mass Spectrom 1989; 18: 321-327.
27. Nelson DE. A new method for carbon isotopic analysis of protein. Science 1991; 251(4993):552-4.
28. 13C sodium bicarbonate infusion and isotope ratio mass spectrometry. Biomed Environ Mass Spectrom 1990; 19:459-4.
29. 13C urea enrichment by gas chromatography/mass spectrometry and gas chromatography/isotope ratio mass spectrometry. Biol Mass Spectrom 1994; 23:510-3.
30. Magot T. La modélisation des métabolismes. Application au métabolisme du cholestérol et des lipoprotéines plasmatiques. Paris: Masson, 1990:29-30.
31. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325:1196-204.
32. Schaefer JR, Scharnagl H, Baumstark MW, Schweer JL, Booth L, Ordovas JM, et al. Homozygous familial defective apolipoprotein B-100. Enhanced removal of apolipoprotein E-containing VLDLs and decreased production of LDLs. Arterioscler Thromb Vasc Biol 1997; 17:348-53.
33. 13C] leucine infusion in normal volunteers. Eur J Clin Invest 1996; 23:602-14.
34. 3]leucine. J Lipid Res 1992; 33:907-14.
35. Cummings MH, Watts GF. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesteryl ester storage disease. Clin Chem 1995; 41:111-4.
36. Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Naoumova R, Slavin BM, et al. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetologia 1995; 38:959-67.
37. Cummings MH, Watts GF, Pal C, Umpleby M, Hennessy TR, Naoumova R, et al. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in obesity: a stable isotope study. Clin Sci 1995; 88:225-33.
38. 15N]glycine precursor enrichment. J Lipid Res 1989; 30:841-6.
39. Cummings MH, Watts GF, Umpleby M, Hennessy TR, Quiney JR, Sönksen PH. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolemia: a stable isotope study. Atherosclerosis 1995; 113:79-89.
40. Watts GF, Naoumova R, Cummings MH, Umpleby AM, Slavin BM, Sönksen PH, et al. Direct correlation between cholesterol synthesis and secretion of apolipoprotein B100 in normolipidemic subjects. Metabolism 1995; 44:1052-7.
41. Parhofer KG, Barrett PHR, Demant T, Richter WO, Schwandt P. Effects of weekly LDL-apheresis on metabolic parameters of apolipoprotein B in heterozygous familial hypercholesterolemia. J Lipid Res 1996; 37:2383-93.
42. Aguilar-Salinas CA, Barrett PHR, Kelber J, Delmez J, Schonfeld G. Physiologic mechanisms of action of lovastatin in nephrotic syndrome. J Lipid Res 1995; 36:188-99.
43. Aguilar-Salinas CA, Barrett PHR, Parhofer KG, Young SG, Tessereau D, Bateman J, et al. Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apolipoprotein B. Arterioscler Thromb Vasc Biol 1995; 15:71-80.
44. Aguilar-Salinas CA, Barrett PHR, Pulai J, Zhu XL, Schonfeld G. A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Arterioscler Thromb Vasc Biol 1997; 17:72-82.
45. Foster DM, Barrett PHR, Bell BM, Cobelli C, Golde JA, Phair RD. SAAM II: simulation, analysis and modelling software. B M E S Bull 1994; 18:19-21.
46. Berman M, Hall M, Levy RI, Eisenberg S, Bilheimer DW, Phair RD, et al. Metabolism of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteinemic subjects. J Lipid Res 1978; 19:38-56.
47. Fisher WR, Zech LA, Bardalaye P, Warmke G, Berman M. The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL. J Lipid Res 1980; 21:760-74.
48. Packard CJ, Gaw A, Demant T, Shepherd J. Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism. J Lipid Res 1995; 36:172-87.
49. Millar JS, Lichtenstein AH, Cuchel M, Dolnikowski G, Hadney DL, Cohn JS, et al. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men. J Lipid Res 1995; 36:1155-67.
50. Maugeais C, Braschi S, Ouguerram K, et al. Lipoprotein kinetics in patients with analbuminemia. Evidence for the role of serum albumin in controlling lipoprotein metabolism. Arterioscler Thromb Vasc Biol 1997; 17:1369-75.
51. Foster DM, Hugh P, Barrett PHR. Considerations in designing and analyzing data from apo-B turnover studies. In: Malmendier CL, editor. Hypercholesterolemia, hypocholesterolemia, hypertriglyceridemia. New York: Plenum Press, 1990:201-11.